Omid Hamid, MD

home / authors / omid-hamid-md

Omid Hamid, MD, is the chief of translational research and immunotherapy and director of melanoma therapeutics at The Angeles Clinic and Research Institute in Los Angeles, California.

Articles

Advancing Melanoma Treatment: Hamid on Lifileucel's Role

Jordyn Sava;Omid Hamid, MD

July 15th 2024

In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.

Current and Emerging Immunotherapeutic Strategies in Melanoma

Omid Hamid, MD

November 12th 2016

Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, discusses current and emerging immunotherapeutic strategies in the field of melanoma during an interview at the 34th Annual Chemotherapy Foundation Symposium<sup>TM</sup>.

Dr. Omid Hamid on the Possibility of Triplet Trials in Melanoma

Omid Hamid, MD

March 12th 2016

Hamid says the future will hold adding more tolerable regimens in to the treatment paradigm of melanoma, based on the past success of the treatments already utilized and approved.

Sequencing and Combining Targeted Therapies in Melanoma

Omid Hamid, MD

March 19th 2015

Omid Hamid, MD, discusses sequencing and combining targeted therapies in the treatment of melanoma.

Combination Therapies in Melanoma

Omid Hamid, MD

November 5th 2013

Omid Hamid, MD, discusses promising combination therapies for the treatment of melanoma.

Treatment Decisions for Patients With Melanoma

Omid Hamid, MD

October 22nd 2013

Omid Hamid, MD, chief, translational research and immunotherapy, director, cutaneous oncology and melanoma, The Angeles Clinic and Research Institute, discusses treatment decisions for patients with melanoma.